Ying Liu   Instructor of Biomedicine in Medicine

Phone
  • +1 212 746 2017

Elucidate the genetic and epigenetic regulation during mammalian stem cell development and tumorigenesis, and how stem cells or tumor cells communicate with their microenvironment.

1. Mammalian spermatogonial stem cells (SSCs)
- Identified the essential role of Spry4–ERK signaling in initiating adult mouse SSCs recovery and sustaining fertility following chemotherapy-induced damage in male reproduction system.
- Developing a three-dimensional semi-physiological culture platform to expand human reproductive tissues in vitro, including SSCs, testicular seminiferous tubules, normal prostate or prostate cancer (PCa) organoids.
- Histone variant H3.3 functions in mammalian SSC homeostasis and germline development 

2. Tumor microenvironment (TME)
- Developing a three-dimensional vascularized tumor organoid culture platform “Tumor-On–VascularNet” with stable blood and nutrient transportation to predict chemoimmunotherapy efficacy in esophageal adenocarcinoma (EAC) patients. 
- Reconstituting tumor microenvironment in vitro with engineered human vascular endothelial cells (R-VECs) and immune cells (macrophages, neutrophils, etc.) to investigate therapy resistance and epigenetic reprogramming within tumor organoids and tumor-associated cells.
- Identifying novel epigenetic targets or biomarkers to improve chemoimmunotherapy efficacy with angiogenesis facilitated tumor organoid culture.
- Optimizing a novel circulating tumor cells (CTCs) culture protocol for patients with metastatic breast cancer or colon cancer using R-VECs and microfluidic enrichment.

Affiliation

Publications

Sort by

selected publications

Research

research overview

  • - Identified the essential role of Spry4–ERK signaling in initiating adult mouse spermatogonial stem cells (SSCs) recovery and sustaining fertility following chemotherapy-induced damage in male reproduction system.
    - Developing a three-dimensional vascularized tumor organoid culture platform “Tumor-On–VascularNet” with stable blood and nutrient transportation to predict chemoimmunotherapy efficacy in esophageal adenocarcinoma (EAC) patients. 
    - Reconstituting tumor microenvironment in vitro with engineered human vascular endothelial cells (R-VECs) and immune cells (macrophages, neutrophils, etc.) to investigate therapy resistance and epigenetic reprogramming within tumor organoids and tumor-associated cells.
    - Optimizing a novel circulating tumor cells (CTCs) culture protocol for patients with metastatic breast cancer or colon cancer using R-VECs and microfluidic enrichment.
    - Identifying novel epigenetic targets or biomarkers to improve chemoimmunotherapy efficacy with angiogenesis facilitated tumor organoid culture.
    - Developing a three-dimensional semi-physiological culture platform to expand human reproductive tissues in vitro, including spermatogonial stem and progenitor cells (SSCs), testicular seminiferous tubules, normal prostate or prostate cancer (PCa) organoids.

keywords

  • Epigenetics, Stem Cell Biology, Tumor Microenvironment

Teaching

Service

Background

Contact

full name

  • Ying Liu

primary email

  • yil2004@med.cornell.edu

additional emails

  • yingliuyl@gmail.com